1. Foreword

   • Elliot G. Brown
   • Stephen A. Goldman

   Foreword 20 November 2012 Pages: 489 - 490

2. Risk Management from an Asian/Pacific Rim Regulatory Perspective

   • John McEwen

   Leading Article 20 November 2012 Pages: 491 - 497

   

3. Risk Management

   • Jane N. S. Moseley

   Leading Article 20 November 2012 Pages: 499 - 508

   

4. CIOMS and ICH Initiatives in Pharmacovigilance and Risk Management

   • Panos Tsintis
   • Edith La Mache

   Leading Article 20 November 2012 Pages: 509 - 517

   

5. Communication of Medical Product Risk

   • Stephen A. Goldman

   Leading Article 20 November 2012 Pages: 519 - 534

   

6. Clinical Pharmacology

   • Kwame N. Atuah
   • Dyfrig Hughes
   • Munir Pirmohamed

   Leading Article 20 November 2012 Pages: 535 - 554

   

7. A Problem-Oriented Approach to Safety Issues in Drug Development and Beyond

   • Joanna F. Haas

   Leading Article 20 November 2012 Pages: 555 - 567

   

8. The Periodic Safety Update Report as a Pharmacovigilance Tool

   • Michael J. Klepper

   Leading Article 20 November 2012 Pages: 569 - 578

   

9. Current Requirements and Emerging Trends for Labelling as a Tool for Communicating Pharmacovigilance Findings

   • A. Leander Fontaine

   Leading Article 20 November 2012 Pages: 579 - 589

   

10. Using MedDRA

    • Elliot G. Brown

    Leading Article 20 November 2012 Pages: 591 - 602

    

11. Crisis Management Strategies

    • Maria C. Koster
    • Helen Politis-Norton

    Leading Article 20 November 2012 Pages: 603 - 608

    

12. Managing the Interface with Marketing to Improve Delivery of Pharmacovigilance Within the Pharmaceutical Industry

    • Brian Edwards

    Leading Article 20 November 2012 Pages: 609 - 617